AstraZeneca
AZN
AZN
402 hedge funds and large institutions have $7.09B invested in AstraZeneca in 2014 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 123 increasing their positions, 135 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.01% more ownership
Funds ownership: 12.78% → 14.79% (+2%)
1% more funds holding
Funds holding: 400 → 402 (+2)
9% less repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 135
Holders
402
Holding in Top 10
10
Calls
$958M
Puts
$511M
Top Buyers
| 1 | +$511M | |
| 2 | +$449M | |
| 3 | +$263M | |
| 4 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$129M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$108M |
Top Sellers
| 1 | -$82.2M | |
| 2 | -$72.3M | |
| 3 | -$66.6M | |
| 4 |
Barclays
London,
United Kingdom
|
-$45.7M |
| 5 |
SCCM
Schafer Cullen Capital Management
New York
|
-$42.1M |